StreetAlpha.app
Home › Stocks › FTRE

Fortrea Holdings Inc. (FTRE)

Healthcare
Members
LATEST PRICE

Fortrea provides clinical trial and drug development services to pharmaceutical, biotechnology and medical device companies. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell).

Prices, price targets and earnings estimates for FTRE are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is FTRE in one of our four AI portfolios? Sign in free to see

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
6firms
5 Buy1 Hold0 Sell
Each firm's latest rating on FTRE in the past 90 days
Average 12-month target
Price targets for FTREThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
Truist SecuritiesTarget raised
Oct 30Buy
BarclaysTarget raised
Oct 30Buy
Evercore ISI GroupMaintained
Oct 30Buy
Deutsche BankUpgrade
Oct 15Buy
BarclaysUpgrade
Oct 6Buy
DateFirmActionRatingPrice target
Oct 30Truist SecuritiesTarget raisedBuy
Oct 30BarclaysTarget raisedBuy
Oct 30Evercore ISI GroupMaintainedBuy
Oct 15Deutsche BankUpgradeBuy
Oct 6BarclaysUpgradeBuy
Loading…

Whale Options Flow

90D

No whale options trades in FTRE in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FTRE is in one of them and how their past FTRE trades turned out.

FTRE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FTRE in an article yet. Here's the latest on the wider market.

FTRE Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Sep 22
Who traded FTRE · since 2025
Latest 2 filings
$15K – $50KTraded Jul 29, 2026Filed Sep 22, 2026
$1K – $15KTraded Jun 23, 2025Filed Jul 24, 2025
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$15K – $50KJul 29, 2026Sep 22, 202655 d
James French HillR · ARSell$1K – $15KJun 23, 2025Jul 24, 202531 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Fortrea Holdings

Fortrea is a contract research organization based in Durham, North Carolina. It provides clinical trial and development services to pharmaceutical, biotechnology and medical device companies. Its offerings include clinical pharmacology studies, full clinical development from early phase through trials after approval, and consulting on product development, regulatory strategy and market access. Customers can choose full service, functional service provider or hybrid delivery models.

Headquarters
Durham, NC